BIOPHARMA INDUSTRY UPDATES | MARCH 2021
Protein implicated in the progression of cardiac disease is a novel biomarker associated with inflammatory status and disease severity in patients with COVID-19
Vertebrate homolog of lin-4 is reported as a novel diagnostic biomarker for cervical cancer, whose expression is significantly lower in cervical cancer patients than those in the healthy controls
Member of the WAP family and encoded by WFDC2 gene is reported as a novel inflammatory biomarker correlated with overall disease severity and the degree of pulmonary dysfunction in patients with cystic fibrosis
Novel biomarker for the diagnosis and monitoring of myasthenia gravis
Bifunctional enzyme with methylene dehydrogenase and cyclohydrolase activity is reported as a novel biomarker for predicting prognosis and pathological stages in patients with esophageal carcinoma
- Cobas BKV (Jan 29, 2021)
Roche Molecular Systems, Inc.
- Immulite 2000 Cortisol (Jan 15, 2021)
Siemens Healthcare Diagnostics Products Ltd.
- LIAISON Testosterone Xt (15 Oct 2020)
- EUROIMMUN Anti-BP230-CF ELISA (IgG) (17 Sep 2020)
Euroimmun US, Inc.
- Lumipulse G CA15-3 (4 Sep 2020)
Fujirebio Diagnostics, Inc.
Clinical Practice Guidelines
Guidelines on the diagnosis and treatment by European Society for Medical Oncology (ESMO)
Guidelines by the European Head and Neck Society (EHNS), European Society for Medical Oncology (ESMO), and European Society for Radiotherapy and Oncology (ESTRO)
Guidelines on the diagnosis and treatment by the European Association of Neuro-Oncology (EANO)
Guidelines on the diagnosis and management by National Comprehensive Cancer Network (NCCN)
Guidelines for the management by American College of Cardiology (ACC) and American Heart Association (AHA)
Tepotinib for Non-Small Cell Lung Cancer; EMD Serono; FDA
Voclosporin for Lupus Nephritis; Aurinia Pharmaceuticals Inc.; FDA
Cabotegravir for HIV Infection; ViiV Healthcare; FDA
Myovant Sciences; FDA
BioCryst Pharmaceuticals, Inc.; FDA
- Posted In: